Top compounds associated with response to MAP2K5


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.022 0.7
mRNA Doxorubicin gCSI pan-cancer AAC -0.019 0.7
mRNA Docetaxel gCSI pan-cancer AAC -0.018 0.8
mRNA Bortezomib gCSI pan-cancer AAC -0.0099 0.9
mRNA Crizotinib gCSI pan-cancer AAC 0.0018 1
mRNA Irinotecan gCSI pan-cancer AAC -0.0011 1
Download CSV